These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22168498)

  • 1. Variation in tissue outcome of ovine and human engineered heart valve constructs: relevance for tissue engineering.
    van Geemen D; Driessen-Mol A; Grootzwagers LG; Soekhradj-Soechit RS; Riem Vis PW; Baaijens FP; Bouten CV
    Regen Med; 2012 Jan; 7(1):59-70. PubMed ID: 22168498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
    Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
    J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia induces near-native mechanical properties in engineered heart valve tissue.
    Balguid A; Mol A; van Vlimmeren MA; Baaijens FP; Bouten CV
    Circulation; 2009 Jan; 119(2):290-7. PubMed ID: 19118259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue.
    Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS
    Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
    Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
    Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves.
    Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA
    Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A xenogeneic acellularized matrix for heart valve tissue engineering: in vivo study in a sheep model].
    Leyh R; Wilhelmi M; Haverich A; Mertsching H
    Z Kardiol; 2003 Nov; 92(11):938-46. PubMed ID: 14634763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased mechanical properties of heart valve tissue constructs cultured in platelet lysate as compared to fetal bovine serum.
    van Geemen D; Riem Vis PW; Soekhradj-Soechit S; Sluijter JP; de Liefde-van Beest M; Kluin J; Bouten CV
    Tissue Eng Part C Methods; 2011 May; 17(5):607-17. PubMed ID: 21284560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
    Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
    Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model.
    Shinoka T; Ma PX; Shum-Tim D; Breuer CK; Cusick RA; Zund G; Langer R; Vacanti JP; Mayer JE
    Circulation; 1996 Nov; 94(9 Suppl):II164-8. PubMed ID: 8901739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
    Engelmayr GC; Sales VL; Mayer JE; Sacks MS
    Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.
    Hoerstrup SP; Kadner A; Melnitchouk S; Trojan A; Eid K; Tracy J; Sodian R; Visjager JF; Kolb SA; Grunenfelder J; Zund G; Turina MI
    Circulation; 2002 Sep; 106(12 Suppl 1):I143-50. PubMed ID: 12354724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue engineering of cardiac valves: re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells.
    Knight RL; Booth C; Wilcox HE; Fisher J; Ingham E
    J Heart Valve Dis; 2005 Nov; 14(6):806-13. PubMed ID: 16359063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous tissue-engineered pulmonary valved stent implantation.
    Lutter G; Metzner A; Jahnke T; Bombien R; Boldt J; Iino K; Cremer J; Stock UA
    Ann Thorac Surg; 2010 Jan; 89(1):259-63. PubMed ID: 20103248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro fabrication of a tissue engineered human cardiovascular patch for future use in cardiovascular surgery.
    Yang C; Sodian R; Fu P; Lüders C; Lemke T; Du J; Hübler M; Weng Y; Meyer R; Hetzer R
    Ann Thorac Surg; 2006 Jan; 81(1):57-63. PubMed ID: 16368335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.
    Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP
    J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro model system to quantify stress generation, compaction, and retraction in engineered heart valve tissue.
    van Vlimmeren MA; Driessen-Mol A; Oomens CW; Baaijens FP
    Tissue Eng Part C Methods; 2011 Oct; 17(10):983-91. PubMed ID: 21609192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human umbilical cord cells for cardiovascular tissue engineering: a comparative study.
    Kadner A; Zund G; Maurus C; Breymann C; Yakarisik S; Kadner G; Turina M; Hoerstrup SP
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):635-41. PubMed ID: 15037283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive and active contributions to generated force and retraction in heart valve tissue engineering.
    van Vlimmeren MA; Driessen-Mol A; Oomens CW; Baaijens FP
    Biomech Model Mechanobiol; 2012 Sep; 11(7):1015-27. PubMed ID: 22246054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-lysate as an autologous alternative for fetal bovine serum in cardiovascular tissue engineering.
    Riem Vis PW; Bouten CV; Sluijter JP; Pasterkamp G; van Herwerden LA; Kluin J
    Tissue Eng Part A; 2010 Apr; 16(4):1317-27. PubMed ID: 19908968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.